Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Sagent Pharmaceuticals Inc

+ Add to Watchlist

SGNT:US

22.4800 USD 0.0900 0.40%

As of 20:10:00 ET on 05/26/2015.

Snapshot for Sagent Pharmaceuticals Inc (SGNT)

Open: 22.5400 Day's Range: 22.2900 - 22.8500 Volume: 226,872
Previous Close: 22.5700 52wk Range: 21.4500 - 33.6000 1-Yr Rtn: -1.83%

Stock Chart for SGNT

No chart data available.
  • SGNT:US 22.4800
  • 1D
  • 1M
  • 1Y
22.5700
Interactive SGNT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SGNT

Current P/E Ratio (ttm) 20.1278
Estimated P/E(12/2015) 80.5735
Relative P/E vs. SPX 1.0826
Earnings Per Share (USD) (ttm) 1.1169
Est. EPS (USD) (12/2015) 0.2790
Est. PEG Ratio 2.2382
Market Cap (M USD) 721.37
Shares Outstanding (M) 32.09
30 Day Average Volume 264,147
Price/Book (mrq) 2.6903
Price/Sale (ttm) 2.3877
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SGNT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SGNT

Sagent Pharmaceuticals Inc. is an injectable pharmaceutical company. The Company offers its customers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

Michael LogerfoPresidentJonathon M SingerExec VP/CFO/Investor Relations
Albert PattersonExec VP:National AccountsLorin DrakeExec VP:Sales
More Company Profile & Key Executives for SGNT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil